Cartesian Therapeutics, Inc. — Form D/A

Cartesian Therapeutics, Inc. of GAITHERSBURG, MD, a company, filed a Form D amendment with the SEC on 2023-12-04. The offering totals $60.3M, of which $60.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (88)

Showing 25 of 88 people.

NameRoleLocation
Timothy S BarabeDirectorGaithersburg, MD
Nishan S De SilvaDirectorGaithersburg, MD
Murat S KalayogluDirectorGaithersburg, MD
Aymeric S SallinDirectorGaithersburg, MD
Michael S SingerDirectorGaithersburg, MD
Timothy S SpringerDirectorDallas, TX
Patrick S ZennerDirectorGaithersburg, MD
Chris S JewellExecutive OfficerGaithersburg, MD
Metin S KurtogluExecutive OfficerGaithersburg, MD
Milos S MiljkovicExecutive OfficerGaithersburg, MD
CARL GORDONDirectorSAN DIEGO, CA
Werner CautreelsDirectorWaltham, MA
Werner CautreelsExecutive OfficerWaltham, MA
Timothy A SpringerDirectorWatertown, MA
Chris A JewellExecutive OfficerGaithersburg, MD
Michael C SingerDirectorGaithersburg, MD
Kemal C MalikDirectorGaithersburg, MD
Carsten BrunnDirectorGaithersburg, MD
Carsten BrunnExecutive OfficerGaithersburg, MD
Metin A KurtogluExecutive OfficerGaithersburg, MD
Timothy C BarabeDirectorGaithersburg, MD
Nishan C de SilvaDirectorGaithersburg, MD
Patrick A ZennerDirectorGaithersburg, MD
Emily A EnglishExecutive OfficerGaithersburg, MD
Carrie S CoxDirectorGaithersburg, MD

Other filings by this issuer (15)

FiledFormOfferingSold
2024-07-17D$130.0M$130.0M
2023-12-01D$60.3M$60.3M
2020-08-18D$25.0M$25.0M
2020-01-02D$70.0M$70.0M
2019-09-04D$5.8M$5.8M
2017-07-11D$50.0M$50.0M
2016-12-14D$5.0M$5.0M
2015-09-10D$40.6M$37.4M
2015-04-23D$7.5M$5.9M
2014-08-28D$4.5M$4.5M
2014-07-15D$6.0M$6.0M
2014-04-09D$10.0M$5.3M
2011-11-17D$26.0M$3.5M
2011-11-17D$22.0M$22.0M
2010-04-06D$15.0M$15.0M

More